Sudarshan Pharma Industries Ltd., a prominent name engaged in the chemical and pharmaceutical business, has announced that its board will meet on January 10, 2025 to evaluate the proposal for raising of funds to augment the financial resources of the Company, by way of issue of securities, convertible instruments, through any permissible method as may be decided by the Board, subject to such regulatory / statutory approvals as may be required, including the approval of shareholders of the Company.
Earlier, the company’ announced its board has approved to acquire 2,09,100 equity-shares of Ishwari Healthcare Private Limited equivalent to 51.00% of the paid up equity share capital of the Company and enter into Share Purchase Agreement. Upon completion of the acquisition, Ishwari Healthcare would become a subsidiary of the Company.
Ishwari Healthcare Private limited is a progressive & innovative Company dedicated to serve world market by providing superior services, user-friendly and state-of-the-art healthcare disposables & devices conforming to international standards at competitive prices. Putting technology to the best use combined with the spirit of innovativeness and creativity, Ishwari Healthcare Private limited provides world-class products to cater the needs of global customers more effectively and efficiently.